2018
DOI: 10.18632/aging.101364
|View full text |Cite
|
Sign up to set email alerts
|

Rapamycin prevents the intervertebral disc degeneration via inhibiting differentiation and senescence of annulus fibrosus cells

Abstract: The effects of bleomycin and rapamycin on cellular senescence and differentiation of rabbit annulus fibrosus stem cells (AFSCs) were investigated using a cell culture model. The results showed that bleomycin induced cellular senescence in AFSCs as evidenced by senescence-associated secretory phenotype. The morphology of AFSCs was changed from cobblestone-like cells to pancake-like cells. The senescence-associated β-galactosidase activity, the protein expression of P16 and P21, and inflammatory-related marker g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(28 citation statements)
references
References 41 publications
0
28
0
Order By: Relevance
“…At present, there are also cytokine-neutralizing antibody therapies for use against senescent cells. Rapamycin is an mTOR inhibitor, and treatment with rapamycin could reduce the expression of MMP-3, MMP-13, IL-1 and IL-6 in rabbit annulus fibrosus stem cells (AFSCs), inhibit mTOR signaling, reduce SASP secretion, regulate the inflammatory response in vivo, and inhibit cell senescence, thus showing potential for the treatment of age-related diseases, 204 including OA.…”
Section: Targeting Of the Subchondral Bone Microenvironment For Oa Anmentioning
confidence: 99%
“…At present, there are also cytokine-neutralizing antibody therapies for use against senescent cells. Rapamycin is an mTOR inhibitor, and treatment with rapamycin could reduce the expression of MMP-3, MMP-13, IL-1 and IL-6 in rabbit annulus fibrosus stem cells (AFSCs), inhibit mTOR signaling, reduce SASP secretion, regulate the inflammatory response in vivo, and inhibit cell senescence, thus showing potential for the treatment of age-related diseases, 204 including OA.…”
Section: Targeting Of the Subchondral Bone Microenvironment For Oa Anmentioning
confidence: 99%
“…Thus, altering the metabolic status of senescence cells may be an important strategy for eliminating the deleterious effects of senescence. Indeed, metabolism-targeting drugs (e.g., rapamycin and etomoxir) have been used to eliminate senescent tumor cells following chemotherapy, leading to suppressed SASP production [ 43 , 46 , 47 ]. Humanin and MOTS-c impact cellular energetics.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, accumulating evidence demonstrates that the senescence of NPCs, as induced by different forms of stress, plays a crucial role in the progression of IDD ( 4 ). As NPCs become senescent, their ability to proliferate is impeded and their functional capability is lost ( 5 ).…”
Section: Introductionmentioning
confidence: 99%